Previous studies showed that DXL6-AS1 aggravated osteosarcoma stemness via Wnt/β-catenin signaling [33]; DLX6-AS1 could also interact with Wnt/β-catenin signaling to promote tumorigenesis in pancreatic cancer [19]. Here, DLX6 is linked to osteosarcoma.